Triste, Sherlyn B.

HRN: 04-46-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/21/2025
07/04/2025
IV
600 Mg
Q6h
Infected Breast Mass
Waiting Final Action 
06/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/21/2025
07/04/2025
IV
1.5g
Q8
Infected Breast Mass
Waiting Final Action 
06/24/2025
CEFTRIAXONE 1G (VIAL)
06/24/2025
06/30/2025
IV
2g
Od
Infected Breast Mass
Waiting Final Action 
07/05/2025
MUPIROCIN 2%, 15G (TUBE)
07/05/2025
07/12/2025
TOPICAL
15g
BID
Decubitus Ulcer
Waiting Final Action 
07/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/07/2025
07/14/2025
IV
4.5g
Q8hrs
SEPTIC SHOCK
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: